THE ROLE OF ANTINEUTROPHIL CYTOPLASM ANTIBODIES, ANTICARDIOLIPIN ANTIBODIES, VONWILLEBRAND-FACTOR ANTIGEN, AND FIBRONECTIN FOR THE DIAGNOSIS OF SYSTEMIC VASCULITIS

被引:0
作者
BLEIL, L
MANGER, B
WINKLER, TH
HERRMAN, M
BURMESTER, GR
KRAPF, FE
KALDEN, JR
机构
关键词
SYSTEMIC VASCULITIS; ANTINEUTROPHIL CYTOPLASMIC ANTIBODIES; ANTICARDIOLIPIN ANTIBODIES; FIBRONECTIN; VONWILLEBRAND FACTOR ANTIGEN;
D O I
暂无
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Autoantibodies directed against cytoplasmic components of neutrophil granulocytes and monocytes (c-ANCA) are a disease specific marker for Wegener's granulomatosis (WG). Autoantibodies against cardiolipin (aCl) are specific for a subgroup of autoimmune disorders, which can also be associated with systemic vasculitis. Fibronectin (Fn) and von Willebrand factor antigen (vWfAg) are produced by blood vessel endothelial cells in response to injury. We tested sera of 61 patients with various types of systemic vasculitides, sera of 13 patients with retinal vasculitis, and sera of 199 patients with rheumatic diseases for c-ANCA, aCl, Fn, and vWfAg. c-ANCA was positive in 14/17 patients with WG, and 2/4 with polyarteritis nodosa (PAN). No serum from healthy donors or patients with other vasculitic or rheumatic diseases was positive for c-ANCA. Moreover, we found aCl, Fn, and vWfAg significantly elevated in almost all patients with vasculitic syndromes. Therefore, we consider c-ANCA a marker, specific for the diagnosis of WG or PAN, whereas aCl, Fn, and vWfAg are nonspecific but sensitive markers of vascular damage.
引用
收藏
页码:1199 / 1206
页数:8
相关论文
共 33 条
[1]   THE AMERICAN-RHEUMATISM-ASSOCIATION 1987 REVISED CRITERIA FOR THE CLASSIFICATION OF RHEUMATOID-ARTHRITIS [J].
ARNETT, FC ;
EDWORTHY, SM ;
BLOCH, DA ;
MCSHANE, DJ ;
FRIES, JF ;
COOPER, NS ;
HEALEY, LA ;
KAPLAN, SR ;
LIANG, MH ;
LUTHRA, HS ;
MEDSGER, TA ;
MITCHELL, DM ;
NEUSTADT, DH ;
PINALS, RS ;
SCHALLER, JG ;
SHARP, JT ;
WILDER, RL ;
HUNDER, GG .
ARTHRITIS AND RHEUMATISM, 1988, 31 (03) :315-324
[2]   VASCULAR DAMAGE AND FACTOR-VIII-RELATED ANTIGEN IN THE RHEUMATIC DISEASES [J].
BELCH, JJF ;
ZOMA, AA ;
RICHARDS, IM ;
MCLAUGHLIN, K ;
FORBES, CD ;
STURROCK, RD .
RHEUMATOLOGY INTERNATIONAL, 1987, 7 (03) :107-111
[3]  
BONEU B, 1975, LANCET, V1, P1430
[4]   LUPUS ANTI-COAGULANT AND INHIBITION OF PROSTACYCLIN FORMATION IN PATIENTS WITH REPEATED ABORTION, INTRAUTERINE GROWTH-RETARDATION AND INTRAUTERINE DEATH [J].
CARRERAS, LO ;
VERMYLEN, J ;
SPITZ, B ;
VANASSCHE, A .
BRITISH JOURNAL OF OBSTETRICS AND GYNAECOLOGY, 1981, 88 (09) :890-894
[5]  
CARSONS S, 1985, J RHEUMATOL, V12, P1088
[6]  
CARSONS S, 1981, ARTHRITIS RHEUM, V24, P1261
[7]   DIFFERENT MOLECULAR-FORMS OF FIBRONECTIN IN RHEUMATOID SYNOVIAL-FLUID [J].
CLEMMENSEN, I ;
ANDERSEN, RB .
ARTHRITIS AND RHEUMATISM, 1982, 25 (01) :25-31
[8]  
CONLEY CL, 1952, J CLIN INVEST, V31, P621
[9]   SEGMENTAL NECROTIZING GLOMERULONEPHRITIS WITH ANTI-NEUTROPHIL ANTIBODY - POSSIBLE ARBOVIRUS ETIOLOGY [J].
DAVIES, DJ ;
MORAN, JE ;
NIALL, JF ;
RYAN, GB .
BMJ-BRITISH MEDICAL JOURNAL, 1982, 285 (6342) :606-606
[10]  
ECHBERG MR, 1976, ANN INTERN MED, V83, P337